GLS2 and neoplasm: L-glutaminase, which hydrolyzes L-glutamine to L-glutamic acid and ammonia, is used in glutamine-deprivation therapy to selectively inhibit tumor growth by blocking de novo protein synthesis and increasing superoxide levels through oxidative stress, leading to the death of cancer cells [101].